CLINICAL_TRIALS
trial_result
· 2025-12-04
Clinical Trial Update: Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome [Phase 2]
Summary
Phase 2 clinical trial evaluating mesenchymal stromal cells for acute respiratory distress syndrome has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael A. Matthay | Conditions: Respiratory Distress Syndrome, Adult | Phase 2 | Status: COMPLETED | Results posted: 2025-12-04